These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35674488)

  • 1. Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery.
    Ow RA; Soler ZM; Sindwani R; Leopold DA; Lee JT; Mahmoud RA; Han JK
    Int Forum Allergy Rhinol; 2023 Jan; 13(1):31-41. PubMed ID: 35674488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
    Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
    Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2).
    Palmer JN; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Messina J; Ow RA; Patel ZM; Peters AT; Sacks H; Schlosser RJ; Sindwani R; Soler ZM; White AA; Wise SK; Mahmoud RA
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1049-1061. PubMed ID: 38244014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.
    Sher MR; Steven GC; Romett JL; Pien G; LeBenger K; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
    Rhinology; 2020 Feb; 58(1):25-35. PubMed ID: 31815255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.
    Leopold DA; Elkayam D; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
    J Allergy Clin Immunol; 2019 Jan; 143(1):126-134.e5. PubMed ID: 29928924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhalation Delivery Systems for Application of Intranasal Corticosteroids.
    Kovacs AJ; Adappa ND; Kuan EC
    Ear Nose Throat J; 2021 Jun; 100(5):309-313. PubMed ID: 33305974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fluticasone Exhalation Delivery System in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
    Wu D; Huang T; Wei Y
    Am J Rhinol Allergy; 2022 Mar; 36(2):176-184. PubMed ID: 34342516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the evidence for fluticasone exhalation delivery system in chronic rhinosinusitis?
    Kovacs AJ; Goshtasbi K; Kuan EC
    Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):14-17. PubMed ID: 31789927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDS-FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trials.
    Wise SK; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Mahmoud R; Messina J; Palmer JN; Patel ZM; Peters AT; Schlosser RJ; Sindwani R; Soler ZM; White AA
    Int Forum Allergy Rhinol; 2024 Dec; 14(12):1892-1903. PubMed ID: 39186196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays.
    Senior BA; Schlosser RJ; Bosso J; Soler ZM
    Int Forum Allergy Rhinol; 2021 May; 11(5):837-845. PubMed ID: 32970395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal Polyps.
    Ow RA; McGinnis JP; Sacks HJ; Mehle ME
    Ear Nose Throat J; 2022 Apr; ():1455613221088698. PubMed ID: 35437059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis.
    Palmer JN; Jacobson KW; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
    Int Forum Allergy Rhinol; 2018 Jun; 8(8):869-76. PubMed ID: 29856520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery.
    Neubauer PD; Schwam ZG; Manes RP
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):233-7. PubMed ID: 26679480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps.
    Rimmer J; Fokkens W; Chong LY; Hopkins C
    Cochrane Database Syst Rev; 2014; 2014(12):CD006991. PubMed ID: 25437000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?
    Kuan EC; Kovacs AJ; Workman AD; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2019 May; 9(S1):S16-S21. PubMed ID: 31087635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study.
    Forwith KD; Han JK; Stolovitzky JP; Yen DM; Chandra RK; Karanfilov B; Matheny KE; Stambaugh JW; Gawlicka AK
    Int Forum Allergy Rhinol; 2016 Jun; 6(6):573-81. PubMed ID: 26992115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessing the Eustachian tube: Conventional nasal spray vs. exhalation delivery system and the impact of targeted endoscopic sinus surgery on topical distribution patterns.
    Axiotakis LG; Spielman DB; Gudis DA; Yang N; Yan CH; Soler ZM; Levy JM; Rowan NR; Irace AL; Vilarello BJ; Jacobson PT; Overdevest JB
    Int Forum Allergy Rhinol; 2024 Mar; 14(3):660-667. PubMed ID: 37533194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II.
    Soler ZM; Colman S; Velez FF; Schlosser RJ
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):848-855. PubMed ID: 32445277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the ocular safety associated with the exhalation delivery system with fluticasone.
    Skoner DP; Meltzer EO; Skoner J; Sacks HJ; Lumry WR
    Allergy Asthma Proc; 2022 Jan; 43(1):70-77. PubMed ID: 34753535
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.